Vinod Raina

6.5k total citations
102 papers, 1.6k citations indexed

About

Vinod Raina is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Vinod Raina has authored 102 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 23 papers in Pathology and Forensic Medicine and 22 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Vinod Raina's work include Chronic Lymphocytic Leukemia Research (13 papers), Breast Cancer Treatment Studies (13 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers). Vinod Raina is often cited by papers focused on Chronic Lymphocytic Leukemia Research (13 papers), Breast Cancer Treatment Studies (13 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers). Vinod Raina collaborates with scholars based in India, United States and United Kingdom. Vinod Raina's co-authors include Nootan Kumar Shukla, Atul Sharma, Sanjay Batra, Gibanananda Ray, Syed Akhtar Husain, S. V. S. Deo, Nalliah Manoharan, Lalit Kumar, Sameer Bakhshi and Atul Sharma and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

Vinod Raina

95 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vinod Raina India 20 645 348 326 324 286 102 1.6k
Tomotaka Ugai Japan 15 662 1.0× 164 0.5× 183 0.6× 318 1.0× 226 0.8× 69 1.4k
Carlo Fabris Italy 29 430 0.7× 145 0.4× 161 0.5× 299 0.9× 382 1.3× 160 3.0k
Alice H. Wang United States 23 659 1.0× 142 0.4× 249 0.8× 338 1.0× 516 1.8× 43 1.5k
Bibhu Ranjan Das India 19 397 0.6× 116 0.3× 224 0.7× 540 1.7× 127 0.4× 86 1.3k
Junshik Hong South Korea 25 685 1.1× 498 1.4× 130 0.4× 325 1.0× 466 1.6× 179 2.0k
Shigetoshi Fujiyama Japan 29 500 0.8× 218 0.6× 295 0.9× 531 1.6× 235 0.8× 124 4.2k
Kaplan Ma Türkiye 21 604 0.9× 602 1.7× 193 0.6× 323 1.0× 104 0.4× 191 1.7k
Prue Hill Australia 21 332 0.5× 257 0.7× 308 0.9× 333 1.0× 295 1.0× 57 1.8k
W P Tong United States 19 1.1k 1.8× 421 1.2× 195 0.6× 506 1.6× 118 0.4× 31 1.8k
Félix Couture Canada 26 1.1k 1.7× 294 0.8× 104 0.3× 491 1.5× 334 1.2× 84 2.3k

Countries citing papers authored by Vinod Raina

Since Specialization
Citations

This map shows the geographic impact of Vinod Raina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vinod Raina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vinod Raina more than expected).

Fields of papers citing papers by Vinod Raina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vinod Raina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vinod Raina. The network helps show where Vinod Raina may publish in the future.

Co-authorship network of co-authors of Vinod Raina

This figure shows the co-authorship network connecting the top 25 collaborators of Vinod Raina. A scholar is included among the top collaborators of Vinod Raina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vinod Raina. Vinod Raina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tyagi, Brij Bhushan, Narendra Kumar Bhardwaj, & Vinod Raina. (2019). Time trends of cancer in a tertiary care centre, 2013-2017. International Journal of Medical and Health Research. 5(11). 152–158. 1 indexed citations
2.
Gogia, Ajay, Vinod Raina, Nootan Kumar Shukla, et al.. (2018). Clinico-pathological characteristics and treatment outcome in invasive lobular carcinoma of the breast: An Indian experience. Indian Journal of Cancer. 55(4). 344–344. 2 indexed citations
3.
Tyagi, Brij Bhushan, et al.. (2017). A profile of common morbidities among geriatric population attending at a new tertiary care institute. International Journal of Medical and Health Research. 3(4). 32–41. 1 indexed citations
4.
Sharma, Atul, et al.. (2015). Old but Still Relevant: High Resolution Electrophoresis and Immunofixation in Multiple Myeloma. Indian Journal of Hematology and Blood Transfusion. 32(1). 10–17. 10 indexed citations
5.
Iqbal, Nida, Atul Sharma, Vinod Raina, et al.. (2014). Poor Response to Standard Chemotherapy in Early T-precursor (ETP)-ALL: A Subtype of T-ALL Associated with Unfavourable Outcome: A Brief Report. Indian Journal of Hematology and Blood Transfusion. 30(4). 215–218. 7 indexed citations
6.
Sharma, Atul, Nootan Kumar Shukla, Richa Jaiswal, et al.. (2013). Gall bladder cancer and the role of dietary and lifestyle factors. European Journal of Cancer Prevention. 22(5). 431–437. 11 indexed citations
7.
Raina, Vinod. (2013). Investigators viewpoint on ethics, methods, and informed consent in clinical trials. Perspectives in Clinical Research. 4(1). 39–39. 1 indexed citations
8.
Tilak, TVSVGK, Vinod Raina, Lalit Kumar, et al.. (2013). Superior vena cava syndrome and poor performance status at presentation affect survival in mediastinal T-lymphoblastic lymphoma—a single institute experience from India. Annals of Hematology. 92(7). 917–923. 7 indexed citations
9.
10.
Gupta, Ajay, et al.. (2010). Dramatic responses to gefitinib when used as front line therapy in two cases of metastatic lung adenocarcinoma with poor performance status. Journal of Cancer Research and Therapeutics. 6(3). 362–362. 2 indexed citations
11.
Sharma, Atul, et al.. (2010). HIV-associated non-Hodgkin′s lymphoma: Experience from a regional cancer center. Indian Journal of Cancer. 47(1). 35–35. 11 indexed citations
12.
Raina, Vinod, et al.. (2007). Long term use of thalidomide: Safe and effective. Indian Journal of Cancer. 44(3). 108–108. 3 indexed citations
13.
Anand, Mona, Rajive Kumar, Sarika Singh, et al.. (2005). Myeloperoxidase cytochemical negativity: an unexpected but intrinsic property of blasts of all phases of chronic myeloid leukemia. Annals of Hematology. 84(12). 767–770. 7 indexed citations
14.
15.
Deo, S. V. S., et al.. (2003). Randomized trial comparing neo‐adjuvant versus adjuvant chemotherapy in operable locally advanced breast cancer (T4b N0‐2 M0). Journal of Surgical Oncology. 84(4). 192–197. 46 indexed citations
16.
Wadhwa, Jyoti, et al.. (2003). POEMS Syndrome: Experience with Fourteen Cases. Leukemia & lymphoma. 44(10). 1749–1752. 35 indexed citations
17.
Grover, J.K, Guldeep Uppal, & Vinod Raina. (2002). The adverse effects of thalidomide in relapsed and refractory patients of multiple myeloma. Annals of Oncology. 13(10). 1636–1640. 28 indexed citations
18.
Asthana, Sonal, et al.. (2001). Carcinoma breast metastatic to the hand and the foot. Australasian Radiology. 45(3). 380–382. 8 indexed citations
19.
20.
Raina, Vinod, et al.. (1993). Brain metastasis as the site of relapse in germ cell tumor of testis. Cancer. 72(7). 2182–2185. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomotaka Ugai Breakdown of academic impact, for papers by Carlo Fabris Breakdown of academic impact, for papers by Alice H. Wang Breakdown of academic impact, for papers by Bibhu Ranjan Das Breakdown of academic impact, for papers by Junshik Hong Breakdown of academic impact, for papers by Shigetoshi Fujiyama Breakdown of academic impact, for papers by Kaplan Ma Breakdown of academic impact, for papers by Prue Hill Breakdown of academic impact, for papers by W P Tong Breakdown of academic impact, for papers by Félix Couture
Rankless by CCL
2026